PMC:7556165 / 68399-68846
Annnotations
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T382 | 69-77 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T383 | 129-139 | Species | denotes | SARS-CoV-2 | NCBItxid:2697049 |
| T384 | 129-133 | Species | denotes | SARS | NCBItxid:694009 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T403 | 0-88 | Sentence | denotes | As evidence builds up, ACE2 rapidly emerged as a specific target for COVID-19 treatment. |
| T404 | 89-393 | Sentence | denotes | Since this enzyme was identified as the SARS-CoV-2 receptor (Zhou et al., 2020), several approaches to address ACE2 mediated infection have been described (Li Y. et al., 2020; Zhang H. et al., 2020), with the aim to prevent host cell entry and subsequent viral replication, as well as severe lung injury. |
| T405 | 394-447 | Sentence | denotes | Potential therapeutic approaches include (Figure 10): |
LitCovid-sample-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T148 | 381-385 | Body_part | denotes | lung | http://purl.obolibrary.org/obo/UBERON_0002048 |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 1868 | 23-27 | Gene | denotes | ACE2 | Gene:59272 |
| 1869 | 200-204 | Gene | denotes | ACE2 | Gene:59272 |
| 1870 | 129-139 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1871 | 69-77 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1872 | 214-223 | Disease | denotes | infection | MESH:D007239 |
| 1873 | 381-392 | Disease | denotes | lung injury | MESH:D055370 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T6119 | 23-27 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
| T6120 | 200-204 | Protein | denotes | ACE2 | https://www.uniprot.org/uniprot/Q9UFZ6 |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T273 | 214-223 | http://purl.obolibrary.org/obo/IDO_0000586 | denotes | infection |
| T274 | 313-317 | http://purl.obolibrary.org/obo/IDO_0000531 | denotes | host |
| T275 | 318-322 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
| T276 | 350-361 | http://purl.obolibrary.org/obo/IDO_0000608 | denotes | replication |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T449 | 318-322 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T450 | 381-385 | Body_part | denotes | lung | http://purl.org/sig/ont/fma/fma7195 |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T401 | 69-77 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T402 | 129-139 | Disease | denotes | SARS-CoV-2 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T403 | 129-133 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
| T404 | 214-223 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
| T405 | 386-392 | Disease | denotes | injury | http://purl.obolibrary.org/obo/MONDO_0021178 |
LitCovid-sample-PD-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T134 | 381-385 | http://purl.obolibrary.org/obo/MAT_0000135 | denotes | lung |
LitCovid-sample-PD-GO-BP-0
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T144 | 344-361 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
| T145 | 344-361 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
LitCovid-sample-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T149 | 344-361 | http://purl.obolibrary.org/obo/GO_0019079 | denotes | viral replication |
| T150 | 344-361 | http://purl.obolibrary.org/obo/GO_0019058 | denotes | viral replication |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1868 | 23-27 | Gene | denotes | ACE2 | Gene:59272 |
| 1869 | 200-204 | Gene | denotes | ACE2 | Gene:59272 |
| 1870 | 129-139 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 1871 | 69-77 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 1872 | 214-223 | Disease | denotes | infection | MESH:D007239 |
| 1873 | 381-392 | Disease | denotes | lung injury | MESH:D055370 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T403 | 0-88 | Sentence | denotes | As evidence builds up, ACE2 rapidly emerged as a specific target for COVID-19 treatment. |
| T404 | 89-393 | Sentence | denotes | Since this enzyme was identified as the SARS-CoV-2 receptor (Zhou et al., 2020), several approaches to address ACE2 mediated infection have been described (Li Y. et al., 2020; Zhang H. et al., 2020), with the aim to prevent host cell entry and subsequent viral replication, as well as severe lung injury. |
| T405 | 394-447 | Sentence | denotes | Potential therapeutic approaches include (Figure 10): |